Result:Weak· Market: Flat#Base effect
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 6.17 | 5.4% | 17.6% |
| Total Income | 6.29 | 5.6% | 17.4% |
| Expenditure | 6.33 | 13.9% | 29.5% |
| PBT | -0.04 | 94.5% | 108.0% |
| Net Profit | -0.04 | 94.5% | 108.0% |
| OPM | 5.57% | 10.68pp | 10.07pp |
| NPM | -0.60% | 9.74pp | 9.36pp |
| EPS | 0.04 | 94.0% | 91.3% |
Diagnostics revenue grew 17.6% YoY but the core P&L swung from profit to a small loss with OPM compressing sharply (15.6%→5.6%), signaling cost/margin deterioration despite top-line growth.
Informational and educational content only. Not investment advice.